Nathalie McKenzie, MD

Board-Certified Gynecologic Oncologist

Focuses on cervical, endometrial, ovarian, vaginal and vulvar cancers
Dr. Nathalie McKenzie

Nathalie Dauphin McKenzie, MD, MSPH, is a board-certified gynecologic oncologist who currently serves as Director of Gynecologic Oncology Fellowship at Florida Hospital Cancer Institute and has affiliate faculty appointments with the FSU and UCF Colleges of Medicine. She earned her medical degree with research honors at the University of Buffalo, New York and undertook residency training and fellowship at the University of Miami/Jackson Memorial Hospital/ Sylvester Comprehensive Cancer Center. She also earned her Master of Science in Public Health and Epidemiology with honors while completing her fellowship training.  Dr. McKenzie who speaks four languages, is recipient of clinical excellence, exemplary physician awards as well as grant recipient of an ASCO Conquer Cancer YIA. She serves a reviewer for multiple journals, is a member of the SGO Wellness Task Force, and the FL, ASCO Clinical Practice Committee.  She has also served as principal investigator for numerous clinical trials, is a member of her institution’s clinical trial monitoring committee, has sat on the board of directors of non-profit organizations, and has gone on numerous medical missions and disaster relief to underdeveloped countries. Her areas of expertise include radical ovarian cancer debulking, robotic and other minimally invasive surgery for various gynecologic cancers including endometrial, cervix, vulvar, and ovarian cancers. She is a thought leader in the oncologic community and frequently lectures throughout the United States and internationally.


  • Advanced Minimally Invasive Surgical Procedures
  • Cervical Cancer
  • HPV-related Neoplasia
  • Laparoscopic and Robotic-Assisted Techniques
  • Ovarian Cancer
  • Radical Debulking Procedures for Advanced Tumors
  • Uterine Cancer
  • Vulvar Cancer
  • Vaginal Cancer


  • Clinical Trials
  • Relapsing, High-Grade Ovarian Cancer
  • Advanced Treatment for Locally Advanced Cervical Cancer
  • HIV-Related Cervical Dysplasia


  • Phase 1 Trial of nelfinavir added to cisplatin chemotherapy with concurrent pelvic radiation for locally advanced cervical cancer
  • HPV in HIV-Infected Women: Implications for Primary Prevention
  • One Size Does Not Fit All: Differences in HPV Knowledge Between Haitian and African American Women


Points of Difference

  • Top 5 Nationally Ranked Gynecologic Robotics Programs
  • Award-Winning Fellowship Program
  • Innovative Robotic Surgery Techniques
  • Internationally Recognized (clinical research, robotic surgery and treatment)
  • Nationally Ranked in Gynecology Oncology
  • Ongoing Research, Publications and Presentations
  • Quality Oncology Practice Initiative (QOPI) Certification

Results & Outcomes

  • Clinical Trials
  • Access to Most Advanced Therapies Available
  • Advanced Stage Gynecologic Cancer Treatment
  • Ongoing Research Projects
  • Ongoing Survival Data and Comparisons
(407) 966-4073